Clinical Advisory Network on Sex and Gender
This article by Dr David Bell and Dr Sinead Helyar examines concerns regarding a proposed clinical trial of puberty blockers (PBs) for children with gender dysphoria. It argues that a PB trial would pose unacceptable risks and contravene ethical standards. The authors advocate alternative avenues for research and safer treatment methods for this vulnerable group of children.
Clinical Advisory Network On Sex & Gender welcomes you to the first in our series of interactive webinars. These webinars will begin to cover the scope of our concerns and our work in the field of sex and gender in health care. Louise Irvine GP and Co-chair of Clinical Advisory Network on Sex and Gender. […]
The closure of the Gender Identity Development Service (GIDS) at the Tavistock has attracted significant public and media attention. Closure resulted from the Cass Review of children and young people’s gender services in England. The interim report recommended a new service model which acknowledges multiple routes in and out of gender dysphoria. Elevated rates of same-sex attraction, autism spectrum disorders, mental health issues, and looked […]
CAN-SG welcome this important intervention by Dr Hilary Cass and support her recommendations that gender questioning young people need a comprehensive patient and family centred service, run by experienced providers of tertiary paediatric care to ensure a focus on child health and development with strong links to mental health services. We support her view that the […]